Lotus Pharmaceuticals Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div yield, %

—

Shrs. gr., 5y

-1.76%

Rev. gr., 5y

Revenues

Net income

-29k

CFO

-19k

L-19.67%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.

Key people

Xing Shen

Vice President - Corporate Development · since 2010

Lu Jun

Director · since 2010

Zhongyi Liu

Chairman of the Board, President, Chief Executive Officer · since 2006

Fan Lijun

Independent Director · since 2010

Li Zhaohui

Independent Director · since 2010

URL

http://www.lotuspharma.com

IPO date

May 15, 2012

Employees

233

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT